Short review – Management of Immune Thrombocytopenia in adults

Weiss, L; Greil, R memo – Magazine of European Medical Oncology (2010) . 2010.

The addition of cetuximab to cisplatin increases overall response rate (ORR) and progression-free survival (PFS) in metastatic triple-negative breast cancer (TNBC): results of a randomized phase II study (BALI-1)

Baselga, J, Gomez, P; Awada, A; Greil, R; Braga, S; Climent, MA; Wardley, A; Zubel, A; Groos, J; Kaufmann, B; Annals of Oncology_x000D_ . 2010. 21: 96-96.

Sunitinib (SU) in combination with docetaxel (D) versus D alone for the first-line treatment of advanced breast cancer (ABC)

Bergh, J; Greil, R; Voytko, N; Makhson, A; Cortes, J; Lortholary, A; Huang, X; Giorgetti, C; Kern, KA; Lichinitser, M; ASCO Annual Meeting Proceedings, 18_suppl, LBA1010_x000D_ _x000D_ _x000D_ . 2010. 28:

Short review – Management of Immune Thrombocytopenia in adults

Weiss, L; Greil, R Magazine of European Medical Oncology. 2010; Volume 3, Issue 2: 69-72.

Targeting gastrin releasing peptide receptors: New options for the therapy and diagnosis of cancer.

Hohla, F; Schally, AV; Cell Cycle. 2010; 9(9): 1738-1741.

Deregulation of p27 and cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients.

Sterlacci, W; Fiegl, M; Hilbe, W; Jamnig, H; Oberaigner, W; Schmid, T; Augustin, F; Auberger, J; Obermann, EC; Tzankov, A; J Thorac Oncol. 2010; 5(9): 1325-1336.

CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B

Leick, M; Catusse, J; Follo, M; Nibbs, RJ; Hartmann, TN; Veelken, H; Burger, M IMMUNOLOGY. 2010; 129(4): 536-546.

PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia, interferes with glucocorticoid-induced apoptosis.

Wasim, M; Carlet, M; Mansha, M; Greil, R; Ploner, C; Trockenbacher, A; Rainer, J; Kofler, R J STEROID BIOCHEM. 2010; 120(4-5): 218-227.

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin“s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

Eich, HT; Diehl, V; Görgen, H; Pabst, T; Markova, J; Debus, J; Ho, A; Dörken, B; Rank, A; Grosu, AL; Wiegel, T; Karstens, JH; Greil, R; Willich, N; Schmidberger, H; Döhner, H; Borchmann, P; Müller-Hermelink, HK; Müller, RP; Engert, A; J Clin Oncol. 2010; 28(27): 4199-4206.

A correlation of endocrine and anticancer effects of some antagonists of GHRH

Kovacs, M; Schally, AV; Hohla, F; Rick, FG; Pozsgai, E; Szalontay, L; Varga, JL; Zarandi, M PEPTIDES. 2010; 31(10): 1839-1846.